오리니아 파마슈티컬스(Aurinia Pharmaceuticals Inc.)
US ˙ NasdaqGM ˙ CA05156V1022

SecurityAUPH / Aurinia Pharmaceuticals Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in AUPH / Aurinia Pharmaceuticals Inc.

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Aurinia Pharmaceuticals Inc. (US:AUPH) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 6,291 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (AUPH) in the form of stock options. The firm currently holds call options representing 390,900 of underlying shares valued at $6,234,855 USD and put options representing 118,000 of underlying shares valued at $1,882,100 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUPH / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -6,291 -100.00 0 -100.00
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 6,291 -54,905 -89.72 53 -89.23 0.0001
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 61,196 -11,698 -16.05 492 -24.77 0.0014
2025-05-14 2024-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 72,894 -277,519 -79.20 655 -74.53 0.0015
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 72,894 -277,519 655 0.0016
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 350,413 350,413 2,569 0.0073
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -377,322 -100.00 0 -100.00
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 377,322 -301,518 -44.42 1,890 -69.03 0.0073
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 678,840 94,458 16.16 6,103 34.41 0.0160
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 584,382 217,289 59.19 4,541 27.78 0.0153
2023-08-09 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 367,093 43,761 13.53 3,553 0.28 0.0114
2023-05-12 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 323,332 6,736 2.13 3,544 159.18 0.0128
2023-02-09 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 316,596 -149,093 -32.02 1,368 -60.97 0.0032
2022-11-09 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 465,689 -2,051 -0.44 3,502 -25.51 0.0069
2022-08-11 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 467,740 83,795 21.82 4,701 -1.09 0.0074
2022-05-12 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 383,945 355,207 1,236.02 4,753 623.44 0.0047
2022-02-11 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 28,738 -27,349 -48.76 657 -47.06 0.0005
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 56,087 -225,564 -80.09 1,241 -66.00 0.0013
2021-08-10 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 281,651 120,178 74.43 3,650 74.06 0.0044
2021-05-12 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 161,473 -156,483 -49.22 2,097 -52.31 0.0031
2021-02-10 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 317,956 -25,137 -7.33 4,397 -13.00 0.0076
2020-11-12 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 343,093 73,862 27.43 5,054 15.52 0.0159
2020-08-13 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 269,231 50,957 23.35 4,375 38.14 0.0202
2020-05-13 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 218,274 47,551 27.85 3,167 -8.44 0.0257
2020-02-10 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 170,723 103,767 154.98 3,459 866.20 0.0235
2019-11-12 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 66,956 54,710 446.76 358 341.98 0.0029
2019-08-09 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 12,246 7,887 180.94 81 189.29 0.0007
2019-05-14 2019-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 4,359 -47,894 -91.66 28 -92.13 0.0003
2019-05-13 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 4,359 -47,894 28
2019-02-05 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 52,253 -63,236 -54.75 356 -53.59 0.0031
2018-11-08 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 115,489 35,699 44.74 767 70.82 0.0061
2018-08-13 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 79,790 -67,061 -45.67 449 -41.08 0.0038
2018-05-16 2018-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 146,851 -80,414 -35.38 762 -26.02 0.0077
2018-05-10 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 146,851 -80,414 762
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 227,265 -34,598 -13.21 1,030 -37.27 0.0072
2017-11-15 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 261,863 26,396 11.21 1,642 13.79 0.0149
2017-08-14 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 235,467 182,416 343.85 1,443 270.95 0.0150
2017-05-10 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 53,051 53,051 389 0.0045
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AURINIA PHARMACEUTICALS COM Call 390,900 14.73 6,235 65.62 n/a n/a n/a
2025-11-12 2025-09-30 13F AURINIA PHARMACEUTICALS COM Call 340,700 13.30 3,765 47.84 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Call 300,700 -34.72 2,547 -31.24 n/a n/a n/a
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM Call 460,600 23.82 3,703 10.87 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AURINIA PHARMACEUTICALS COM Call 372,000 -28.83 3,341 -12.82 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Call 372,000 3,341 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Call 522,700 -2.77 3,831 24.83 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Call 537,600 15.46 3,070 31.60 n/a n/a n/a
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM Call 465,600 -47.11 2,333 -70.53 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Call 880,300 34.56 7,914 55.68 n/a n/a n/a
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM Call 654,200 -29.14 5,083 -43.12 n/a n/a n/a
2023-08-09 2023-06-30 13F AURINIA PHARMACEUTICALS COM Call 923,200 26.73 8,937 11.92 n/a n/a n/a
2023-05-12 2023-03-31 13F AURINIA PHARMACEUTICALS COM Call 728,500 11.53 7,984 183.02 n/a n/a n/a
2023-02-09 2022-12-31 13F AURINIA PHARMACEUTICALS COM Call 653,200 5.76 2,822 -39.25 n/a n/a n/a
2022-11-09 2022-09-30 13F AURINIA PHARMACEUTICALS COM Call 617,600 63.56 4,644 22.37 n/a n/a n/a
2022-08-11 2022-06-30 13F AURINIA PHARMACEUTICALS COM Call 377,600 -38.07 3,795 -49.72 n/a n/a n/a
2022-05-12 2022-03-31 13F AURINIA PHARMACEUTICALS COM Call 609,700 -48.42 7,548 -72.08 n/a n/a n/a
2022-02-11 2021-12-31 13F AURINIA PHARMACEUTICALS COM Call 1,182,000 86.55 27,032 92.78 n/a n/a n/a
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM Call 633,600 201.43 14,022 414.76 n/a n/a n/a
2021-08-10 2021-06-30 13F AURINIA PHARMACEUTICALS COM Call 210,200 12.29 2,724 12.05 n/a n/a n/a
2021-05-12 2021-03-31 13F AURINIA PHARMACEUTICALS COM Call 187,200 -49.14 2,431 -52.25 n/a n/a n/a
2021-02-10 2020-12-31 13F AURINIA PHARMACEUTICALS COM Call 368,100 64.77 5,091 54.69 n/a n/a n/a
2020-11-12 2020-09-30 13F AURINIA PHARMACEUTICALS COM Call 223,400 20.82 3,291 9.52 n/a n/a n/a
2020-08-13 2020-06-30 13F AURINIA PHARMACEUTICALS COM Call 184,900 -39.67 3,005 -32.43 n/a n/a n/a
2020-05-13 2020-03-31 13F AURINIA PHARMACEUTICALS COM Call 306,500 -26.32 4,447 -47.24 n/a n/a n/a
2020-02-10 2019-12-31 13F AURINIA PHARMACEUTICALS COM Call 416,000 231.74 8,428 1,157.91 n/a n/a n/a
2019-11-12 2019-09-30 13F AURINIA PHARMACEUTICALS COM Call 125,400 202.17 670 145.42 n/a n/a n/a
2019-08-09 2019-06-30 13F AURINIA PHARMACEUTICALS COM Call 41,500 -13.54 273 -12.50 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AURINIA PHARMACEUTICALS COM Call 48,000 451.72 312 428.81 n/a n/a n/a
2019-05-13 2019-03-31 13F AURINIA PHARMACEUTICALS COM Call 48,000 312 n/a n/a n/a
2019-02-05 2018-12-31 13F AURINIA PHARMACEUTICALS COM Call 8,700 -91.26 59 -91.07 n/a n/a n/a
2018-11-08 2018-09-30 13F AURINIA PHARMACEUTICALS COM Call 99,500 -2.36 661 15.16 n/a n/a n/a
2018-08-13 2018-06-30 13F AURINIA PHARMACEUTICALS COM Call 101,900 133.18 574 152.86 n/a n/a n/a
2018-05-16 2018-03-31 13F/A AURINIA PHARMACEUTICALS COM Call 43,700 -63.73 227 -58.42 n/a n/a n/a
2018-05-10 2018-03-31 13F AURINIA PHARMACEUTICALS COM Call 43,700 227 n/a n/a n/a
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS COM Call 120,500 1,621.43 546 1,140.91 n/a n/a n/a
2017-11-15 2017-09-30 13F AURINIA PHARMACEUTICALS COM Call 7,000 -85.11 44 -84.72 n/a n/a n/a
2017-08-14 2017-06-30 13F AURINIA PHARMACEUTICALS COM Call 47,000 -82.63 288 -85.50 n/a n/a n/a
2017-05-10 2017-03-31 13F AURINIA PHARMACEUTICALS COM Call 270,600 171.14 1,986 845.71 n/a n/a n/a
2017-02-15 2016-12-31 13F AURINIA PHARMACEUTICALS COM Call 99,800 210 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AURINIA PHARMACEUTICALS COM Put 118,000 -36.66 1,882 -8.55 n/a n/a n/a
2025-11-12 2025-09-30 13F AURINIA PHARMACEUTICALS COM Put 186,300 104.73 2,059 167.27 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Put 91,000 -16.05 771 -11.60 n/a n/a n/a
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM Put 108,400 -40.86 872 -47.08 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AURINIA PHARMACEUTICALS COM Put 183,300 -91.22 1,646 -89.24 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Put 183,300 1,646 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Put 2,086,900 762.36 15,297 1,007.60 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Put 242,000 -78.34 1,382 -75.33 n/a n/a n/a
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM Put 1,117,500 32.55 5,599 -26.14 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Put 843,100 74.45 7,579 101.84 n/a n/a n/a
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM Put 483,300 21.04 3,755 -2.85 n/a n/a n/a
2023-08-09 2023-06-30 13F AURINIA PHARMACEUTICALS COM Put 399,300 81.34 3,865 60.17 n/a n/a n/a
2023-05-12 2023-03-31 13F AURINIA PHARMACEUTICALS COM Put 220,200 113.58 2,413 442.25 n/a n/a n/a
2023-02-09 2022-12-31 13F AURINIA PHARMACEUTICALS COM Put 103,100 -57.69 445 -75.72 n/a n/a n/a
2022-11-09 2022-09-30 13F AURINIA PHARMACEUTICALS COM Put 243,700 35.24 1,833 1.21 n/a n/a n/a
2022-08-11 2022-06-30 13F AURINIA PHARMACEUTICALS COM Put 180,200 8.10 1,811 -12.26 n/a n/a n/a
2022-05-12 2022-03-31 13F AURINIA PHARMACEUTICALS COM Put 166,700 -70.51 2,064 -84.03 n/a n/a n/a
2022-02-11 2021-12-31 13F AURINIA PHARMACEUTICALS COM Put 565,200 2.78 12,926 6.22 n/a n/a n/a
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM Put 549,900 129.89 12,169 292.55 n/a n/a n/a
2021-08-10 2021-06-30 13F AURINIA PHARMACEUTICALS COM Put 239,200 97.20 3,100 96.83 n/a n/a n/a
2021-05-12 2021-03-31 13F AURINIA PHARMACEUTICALS COM Put 121,300 34.63 1,575 26.40 n/a n/a n/a
2021-02-10 2020-12-31 13F AURINIA PHARMACEUTICALS COM Put 90,100 -21.99 1,246 -26.75 n/a n/a n/a
2020-11-12 2020-09-30 13F AURINIA PHARMACEUTICALS COM Put 115,500 -18.26 1,701 -25.91 n/a n/a n/a
2020-08-13 2020-06-30 13F AURINIA PHARMACEUTICALS COM Put 141,300 -43.53 2,296 -36.75 n/a n/a n/a
2020-05-13 2020-03-31 13F AURINIA PHARMACEUTICALS COM Put 250,200 -42.40 3,630 -58.75 n/a n/a n/a
2020-02-10 2019-12-31 13F AURINIA PHARMACEUTICALS COM Put 434,400 224.91 8,801 1,132.63 n/a n/a n/a
2019-11-12 2019-09-30 13F AURINIA PHARMACEUTICALS COM Put 133,700 461.76 714 354.78 n/a n/a n/a
2019-08-09 2019-06-30 13F AURINIA PHARMACEUTICALS COM Put 23,800 93.50 157 96.25 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AURINIA PHARMACEUTICALS COM Put 12,300 -71.72 80 -73.06 n/a n/a n/a
2019-05-13 2019-03-31 13F AURINIA PHARMACEUTICALS COM Put 12,300 80 n/a n/a n/a
2019-02-05 2018-12-31 13F AURINIA PHARMACEUTICALS COM Put 43,500 -65.86 297 -64.89 n/a n/a n/a
2018-11-08 2018-09-30 13F AURINIA PHARMACEUTICALS COM Put 127,400 1.51 846 19.66 n/a n/a n/a
2018-08-13 2018-06-30 13F AURINIA PHARMACEUTICALS COM Put 125,500 -41.79 707 -36.82 n/a n/a n/a
2018-05-16 2018-03-31 13F/A AURINIA PHARMACEUTICALS COM Put 215,600 -33.56 1,119 -23.88 n/a n/a n/a
2018-05-10 2018-03-31 13F AURINIA PHARMACEUTICALS COM Put 215,600 1,119 n/a n/a n/a
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS COM Put 324,500 30.22 1,470 -5.89 n/a n/a n/a
2017-11-15 2017-09-30 13F AURINIA PHARMACEUTICALS COM Put 249,200 3.53 1,562 5.90 n/a n/a n/a
2017-08-14 2017-06-30 13F AURINIA PHARMACEUTICALS COM Put 240,700 -7.35 1,475 -22.65 n/a n/a n/a
2017-05-10 2017-03-31 13F AURINIA PHARMACEUTICALS COM Put 259,800 2,498.00 1,907 8,980.95 n/a n/a n/a
2017-02-15 2016-12-31 13F AURINIA PHARMACEUTICALS COM Put 10,000 21 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.